Mechanistically, HNF4A-AS1 was found to inhibit the stability of AGR2 mRNA by promoting the proteasomal degradation of PCBP2, thereby participating in the regulation of the malignant phenotype of HCC. Here, HNF4A is linked to hepatocellular carcinoma.